Filing Details
- Accession Number:
- 0001415889-24-020431
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-31 16:30:10
- Reporting Period:
- 2024-07-29
- Accepted Time:
- 2024-07-31 16:30:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-07-29 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-07-29 | 229 | $332.67 | 3,501 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-29 | 989 | $333.85 | 2,512 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-29 | 802 | $334.84 | 1,710 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-29 | 452 | $335.81 | 1,258 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-29 | 335 | $337.24 | 923 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-29 | 247 | $337.90 | 676 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-29 | 421 | $339.54 | 255 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-29 | 125 | $340.29 | 130 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-07-30 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-07-30 | 98 | $334.48 | 3,632 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-30 | 515 | $335.73 | 3,117 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-30 | 1,432 | $336.81 | 1,685 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-30 | 822 | $337.75 | 863 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-30 | 453 | $338.98 | 410 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-30 | 138 | $340.03 | 272 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-30 | 142 | $341.76 | 130 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2024-07-29 | 3,600 | $0.00 | 3,600 | $129.49 |
Common Stock | Stock Options | Disposition | 2024-07-30 | 3,600 | $0.00 | 3,600 | $129.49 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
68,669 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
65,069 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 166 | Indirect | By Spouse |
Common Stock | 245,909 | Indirect | By Trust |
Common Stock | 1,742 | Indirect | By Trust |
Common Stock | 28,170 | Indirect | By Trust |
Common Stock | 324,518 | Indirect | By Trust |
Common Stock | 45,596 | Indirect | By Trust |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
- This transaction was executed in multiple trades at prices ranging from $332.315 to $333.155. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $333.385 to $334.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $334.425 to $335.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $335.56 to $336.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $336.615 to $337.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $337.67 to $338.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $339.05 to $339.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $334.155 to $334.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $335.205 to $336.165. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $336.225 to $337.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $337.245 to $338.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $338.465 to $339.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $339.955 to $340.805. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $341.065 to $341.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- Shares held in family trusts as to which the Reporting Person is sole trustee and members of the Reporting Person's immediate family are beneficiaries.
- Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.